Keywords: epistent, update, confirms, reopro, role, stenting, six-month

EPISTENT Update Confirms ReoPro Role In Stenting

Article | 01 September 1998

Print This

Six-month follow-up data from the first trial of glycoprotein IIb/IIIareceptor blockade in coronary stenting - EPISTENT - have confirmed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in